Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Takeda exercises option to acquire Maverick Therapeutics for $525m

pharmaceutical-technologyMarch 11, 2021

Tag: Takeda , Maverick , TAK-186 , TAK-280 , acquisition

PharmaSources Customer Service